Wed, 30th Dec 2020 07:30
LONDON, Dec 30 (Reuters) - The approval of a COVID-19
vaccine developed by the University of Oxford and AstraZeneca on
Wednesday was a "triumph for British science", Prime Minister
Boris Johnson said.
"It is truly fantastic news - and a triumph for British
science - that the @UniofOxford/@AstraZeneca vaccine has been
approved for use," Johnson tweeted.
(Reporting by Guy Faulconbridge and Paul Sandle, editing by
David Milliken)
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:
BEIJING, May 22 (Reuters) - British firms expect doing business in China to become harder over the next five years, a British business lobby group s...
(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in Lond...
Focus on Fed minutes, Nvidia earnings *
(Alliance News) - Stock prices in London closed in the red on Tuesday, as investors nervously eye a key UK inflation reading, which could prompt the B...
Astrazeneca (AZN)